- HOME
- Innovation and Technological Development
Innovation and Technological Development
Innovation at the Service of MENTAL Health
At Grupo Neolpharma, innovation drives us to transform the future of healthcare in Mexico. Through our Office of Innovation and Academia–Industry Collaboration, we connect scientific knowledge with real-world solutions that improve people’s lives..
Our Focus Areas
We concentrate our R&D efforts on key areas that respond to today’s most urgent health challenges:
-
Psychiatric and Neurological Disorders: Developing new treatments to enhance quality of life. -
Advanced Drug Delivery Systems: Improving therapeutic efficacy and patient experience.
-
Pharmacological Combinations: Creating synergistic therapies for better outcomes. -
Digital Ecosystems: Integrating technology to improve access and follow-up in care.
Collaboration that Transforms
We partner with Mexico’s top universities and research centers to promote student mobility, internships, and postgraduate training—nurturing national talent and scientific growth.
World-Class Infrastructure
Our research and production capabilities include:
6 pharmaceutical plants for oral solids, injectables, and parenterals.
2 API synthesis plants.
1 biotechnology plant.
A pilot plant for development and scale-up.
Specialized analytical laboratories.
Recognizing Scientific Excellence
We proudly promote research through two major awards:
Bionano Award for Innovation in Nanotechnology, supporting projects with real-world health applications.
Matilde Montoya Award, honoring women scientists whose work advances public health and gender equity.
A Story of Innovation
In 2009, a landmark partnership between UNAM, INCAN, and Psicofarma gave rise to Transkrip, an epigenetic therapy that enhances chemotherapy—proof that collaboration between science and industry can transform health in Mexico.
Learn more or collaborate with us:
